292 related articles for article (PubMed ID: 24960584)
21. Electroporation optimizes the uptake of boron-10 by tumor for boron neutron capture therapy (BNCT) mediated by GB-10: a boron biodistribution study in the hamster cheek pouch oral cancer model.
Garabalino MA; Olaiz N; Portu A; Saint Martin G; Thorp SI; Pozzi ECC; Curotto P; Itoiz ME; Monti Hughes A; Colombo LL; Nigg DW; Trivillin VA; Marshall G; Schwint AE
Radiat Environ Biophys; 2019 Aug; 58(3):455-467. PubMed ID: 31123853
[TBL] [Abstract][Full Text] [Related]
22. Biodistribution of a carborane-containing porphyrin as a targeting agent for Boron Neutron Capture Therapy of oral cancer in the hamster cheek pouch.
Kreimann EL; Miura M; Itoiz ME; Heber E; Garavaglia RN; Batistoni D; Rebagliati RJ; Roberti MJ; Micca PL; Coderre JA; Schwint AE
Arch Oral Biol; 2003 Mar; 48(3):223-32. PubMed ID: 12648560
[TBL] [Abstract][Full Text] [Related]
23. Boron neutron capture therapy for oral precancer: proof of principle in an experimental animal model.
Monti Hughes AM; Pozzi EC; Thorp S; Garabalino MA; Farías RO; González SJ; Heber EM; Itoiz ME; Aromando RF; Molinari AJ; Miller M; Nigg DW; Curotto P; Trivillin VA; Schwint AE
Oral Dis; 2013 Nov; 19(8):789-95. PubMed ID: 23410091
[TBL] [Abstract][Full Text] [Related]
24. Effects of boron neutron capture therapy on human oral squamous cell carcinoma in a nude mouse model.
Kamida A; Obayashi S; Kato I; Ono K; Suzuki M; Nagata K; Sakurai Y; Yura Y
Int J Radiat Biol; 2006 Jan; 82(1):21-9. PubMed ID: 16546900
[TBL] [Abstract][Full Text] [Related]
25. Histamine reduces boron neutron capture therapy-induced mucositis in an oral precancer model.
Monti Hughes A; Pozzi E; Thorp SI; Curotto P; Medina VA; Martinel Lamas DJ; Rivera ES; Garabalino MA; Farías RO; Gonzalez SJ; Heber EM; Itoiz ME; Aromando RF; Nigg DW; Trivillin VA; Schwint AE
Oral Dis; 2015 Sep; 21(6):770-7. PubMed ID: 25926141
[TBL] [Abstract][Full Text] [Related]
26. Enhancement in the Therapeutic Efficacy of In Vivo BNCT Mediated by GB-10 with Electroporation in a Model of Oral Cancer.
Olaiz N; Monti Hughes A; Pozzi ECC; Thorp S; Curotto P; Trivillin VA; Ramos PS; Palmieri MA; Marshall G; Schwint AE; Garabalino MA
Cells; 2023 Apr; 12(9):. PubMed ID: 37174642
[TBL] [Abstract][Full Text] [Related]
27. Different oral cancer scenarios to personalize targeted therapy: Boron Neutron Capture Therapy translational studies.
Hughes AM; Goldfinger JA; Santa Cruz IS; Pozzi EC; Thorp S; Curotto P; Garabalino MA; Itoiz ME; Palmieri MA; Ramos P; Heber EM; Aromando RF; Nigg DW; Koivunoro H; Trivillin VA; Schwint AE
Ther Deliv; 2019 Jun; 10(6):353-362. PubMed ID: 31184544
[TBL] [Abstract][Full Text] [Related]
28. Optimization of boron neutron capture therapy for the treatment of undifferentiated thyroid cancer.
Dagrosa MA; Thomasz L; Longhino J; Perona M; Calzetta O; Blaumann H; Rebagliati RJ; Cabrini R; Kahl S; Juvenal GJ; Pisarev MA
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1059-66. PubMed ID: 17967301
[TBL] [Abstract][Full Text] [Related]
29. Biodistribution of the boron carriers boronophenylalanine (BPA) and/or decahydrodecaborate (GB-10) for Boron Neutron Capture Therapy (BNCT) in an experimental model of lung metastases.
Trivillin VA; Garabalino MA; Colombo LL; González SJ; Farías RO; Monti Hughes A; Pozzi EC; Bortolussi S; Altieri S; Itoiz ME; Aromando RF; Nigg DW; Schwint AE
Appl Radiat Isot; 2014 Jun; 88():94-8. PubMed ID: 24360862
[TBL] [Abstract][Full Text] [Related]
30. Macro- and microdistributions of boron drug for boron neutron capture therapy in an animal model.
Lin YC; Hwang JJ; Wang SJ; Yang BH; Chang CW; Hsiao MC; Chou FI
Anticancer Res; 2012 Jul; 32(7):2657-64. PubMed ID: 22753723
[TBL] [Abstract][Full Text] [Related]
31. Suitability of boron carriers for BNCT: accumulation of boron in malignant and normal liver cells after treatment with BPA, BSH and BA.
Chou FI; Chung HP; Liu HM; Chi CW; Lui WY
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S105-8. PubMed ID: 19375330
[TBL] [Abstract][Full Text] [Related]
32. Quantitative imaging and microlocalization of boron-10 in brain tumors and infiltrating tumor cells by SIMS ion microscopy: relevance to neutron capture therapy.
Smith DR; Chandra S; Barth RF; Yang W; Joel DD; Coderre JA
Cancer Res; 2001 Nov; 61(22):8179-87. PubMed ID: 11719448
[TBL] [Abstract][Full Text] [Related]
33. Boron delivery with liposomes for boron neutron capture therapy (BNCT): biodistribution studies in an experimental model of oral cancer demonstrating therapeutic potential.
Heber EM; Kueffer PJ; Lee MW; Hawthorne MF; Garabalino MA; Molinari AJ; Nigg DW; Bauer W; Hughes AM; Pozzi EC; Trivillin VA; Schwint AE
Radiat Environ Biophys; 2012 May; 51(2):195-204. PubMed ID: 22271404
[TBL] [Abstract][Full Text] [Related]
34. Boron neutron capture therapy as new treatment for clear cell sarcoma: trial on different animal model.
Andoh T; Fujimoto T; Sudo T; Suzuki M; Sakurai Y; Sakuma T; Moritake H; Sugimoto T; Takeuchi T; Sonobe H; Epstein AL; Fukumori Y; Ono K; Ichikawa H
Appl Radiat Isot; 2014 Jun; 88():59-63. PubMed ID: 24389062
[TBL] [Abstract][Full Text] [Related]
35. Improvement of the tumor-suppressive effect of boron neutron capture therapy for amelanotic melanoma by intratumoral injection of the tyrosinase gene.
Morita N; Hiratsuka J; Kondoh H; Uno M; Asano T; Niki Y; Sakurai Y; Ono K; Harada T; Imajo Y
Cancer Res; 2006 Apr; 66(7):3747-53. PubMed ID: 16585201
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic efficacy of boron neutron capture therapy mediated by boron-rich liposomes for oral cancer in the hamster cheek pouch model.
Heber EM; Hawthorne MF; Kueffer PJ; Garabalino MA; Thorp SI; Pozzi EC; Monti Hughes A; Maitz CA; Jalisatgi SS; Nigg DW; Curotto P; Trivillin VA; Schwint AE
Proc Natl Acad Sci U S A; 2014 Nov; 111(45):16077-81. PubMed ID: 25349432
[TBL] [Abstract][Full Text] [Related]
37. BNCT of 3 cases of spontaneous head and neck cancer in feline patients.
Rao M; Trivillin VA; Heber EM; Cantarelli Mde L; Itoiz ME; Nigg DW; Rebagliati RJ; Batistoni D; Schwint AE
Appl Radiat Isot; 2004 Nov; 61(5):947-52. PubMed ID: 15308173
[TBL] [Abstract][Full Text] [Related]
38. Effect of Boron Neutron Capture Therapy (BNCT) on normal liver regeneration: towards a novel therapy for liver metastases.
Cardoso JE; Trivillin VA; Heber EM; Nigg DW; Calzetta O; Blaumann H; Longhino J; Itoiz ME; Bumaschny E; Pozzi E; Schwint AE
Int J Radiat Biol; 2007 Oct; 83(10):699-706. PubMed ID: 17729164
[TBL] [Abstract][Full Text] [Related]
39. Selective uptake of p-borophenylalanine by undifferentiated thyroid carcinoma for boron neutron capture therapy.
Dagrosa MA; Viaggi M; Kreimann E; Farías S; Garavaglia R; Agote M; Cabrini RL; Dadino JL; Juvenal GJ; Pisarev MA
Thyroid; 2002 Jan; 12(1):7-12. PubMed ID: 11838734
[TBL] [Abstract][Full Text] [Related]
40. Dose-rate effect was observed in T98G glioma cells following BNCT.
Kinashi Y; Okumura K; Kubota Y; Kitajima E; Okayasu R; Ono K; Takahashi S
Appl Radiat Isot; 2014 Jun; 88():81-5. PubMed ID: 24360864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
